Ji-Oh Mok

6PUBLICATIONS
33CO-AUTHORS
Pharmaceutical delivery technologiesInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)Motor controlMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial.

Soo Lim, Tae Nyun Kim, Ji Oh Mok

|Jan 09, 2026
First Report of Lipoprotein X Formation in Methimazole-Induced Cholestatic Jaundice with Agranulocytosis.

Yoon E Shin, Hyun Ju Lee, Yoon Young Cho

|Jul 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Eun-Gyoung Hong, Kyung-Wan Min, SungWan Chun

|Oct 08, 2024
Low muscle strength rather than low muscle mass is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.

Chan-Hee Jung, Yoon Young Cho, Dug-Hyun Choi

|Dec 19, 2022
Recent Updates on Associations among Various Obesity Metrics and Cognitive Impairment: from Body Mass Index to Sarcopenic Obesity.

Chan-Hee Jung, Ji-Oh Mok

|Sep 20, 2018
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.

Dug Hyun Choi, Chan Hee Jung, Ji Oh Mok

Pageof 1

Frequent Collaborators

3 joint publications

Chan-Hee Jung

2 joint publications

Dughyun Choi

2 joint publications

Chul-Hee Kim

2 joint publications

Bo-Yeon Kim